argustrial.com | Argus - A Dravet SyndromeClinical

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow:

Meta Tags

Title	Argus - A Dravet SyndromeClinical
Description	Argus trial is a multicenter clinical study investigating EPX-100 (ClemizoleHCl) to alleviate seizures in Children and Adult Participants with Dravet
Keywords	N/A

Server Information

WebSite	argustrial.com
Host IP	209.59.168.57
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

argustrial.com Valuation

US$1,365

Last updated: 2023-05-20 08:01:41

argustrial.com has Semrush global rank of 0. argustrial.com has an estimated worth of US$ 1,365, based on its estimated Ads revenue. argustrial.com receives approximately 157 unique visitors each day. Its web server is located in United States, with IP address 209.59.168.57. According to SiteAdvisor, argustrial.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,365
Daily Ads Revenue	US$1
Monthly Ads Revenue	US$37
Yearly Ads Revenue	US$453
Daily Unique Visitors	10
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
argustrial.com.	A	598	IP: 209.59.168.57
argustrial.com.	NS	3600	NS Record: ns34.domaincontrol.com.
argustrial.com.	NS	3600	NS Record: ns33.domaincontrol.com.

HtmlToTextCheckTime:2023-05-20 08:01:41

Argus About Argus Quick Facts Study Drug Study Locations Contact English Français Español Argus A Dravet Syndrome Clinical Study Argus trial is a multicenter clinical study investigating EPX-100 (Clemizole HCl) to alleviate seizures in Children and Adult Participants with Dravet syndrome Find Your Nearest Study Center This is the first time that the study drug will be given to a patient with Dravet syndrome, and your child will be carefully monitored for safety and efficacy during the study. Half of the participants will be given a placebo (drug-free oral liquid solution), but your child will not know which treatment has been administered. The study will also look at: If the study drug affects the general well-being of patients with Dravet syndrome. If there are any safety concerns for patients. How fast the study drug is removed from the body. Up to 100 patients with Dravet syndrome from US, Canada, UK and Spain will take part in the study. About The Argus Trial The Argus trial is

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Wed, 25 Jan 2023 09:11:53 GMT
Server: Apache
X-Redirect-By: WordPress
Location: https://argustrial.com/
Cache-Control: max-age=600
Expires: Wed, 25 Jan 2023 09:21:53 GMT
Vary: User-Agent
Content-Type: text/html; charset=UTF-8

HTTP/1.1 200 OK
Date: Wed, 25 Jan 2023 09:11:54 GMT
Server: Apache
Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
Cache-Control: max-age=600
Expires: Wed, 25 Jan 2023 09:21:54 GMT
Vary: User-Agent
Content-Type: text/html; charset=UTF-8

argustrial.com valuation and analysis